Autopsy report · NCT04649775

AirFLO2 Treatment for Hypoxia and/or Tachypnea in Patients With COVID-19

“no eligible participants”

The sponsor’s own words in the registry.

Life of this trial

• Registered 6 months before it started.
• Ran for about 7 months before it stopped.
• 11 participants enrolled.
• Results were posted on the registry 1 year 1 month after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Duke University

Sponsor type

University, hospital or other

Conditions

Corona Virus Infection; Respiratory Rate; Hypoxia; Covid19

Interventions

AirFLO2

Participants

11

Sites

1

Countries

United States

Trials that died the same way

• Implementation of STTR Strategies Among People Who Inject Drugs in Malaysia
  “lack of eligible participants” (88% match in meaning)
• Project 1: ACHIEVE- HTN
  “Due lack of eligible participants” (85% match in meaning)
• Validation of the Prostate Cancer Assay - Beta+Pivotal
  “No enrolled participants” (85% match in meaning)
• The Relationship Between Clotting Factor VIII and Bleeding Adverse Reactions in Patients Under the Therapies of Thrombolysis, Anticoagulation and Anti-platelet
  “No participants enrolled” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.